Position in ZTS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$517,523
+$165,839 QoQ
Shares Held
4,378
+143.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Catalyst Funds Management Pty Ltd holds $2,610,858 across 5 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
13,400 | $856,930 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,441 | $780,777 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,600 | $438,204 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,900 | $292,539 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
9,850 | $242,408 |
All Filings in ZTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $517,523 | 4,378 | Shares | Sole | 2026-05-11 | |
| 2024-09-30 | $351,684 | 1,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $104,016 | 600 | Shares | Sole | 2024-12-18 | |
| No filing history on record for this holder in this stock. | ||||||